Want to see HK:8217 full AI Analyst Report?

Luen Wong Group Holdings Ltd. (8217) Price & Analysis

0 Followers

8217 Stock Chart & Stats

HK$0.38

HK$0.00(0.00%)

At close: Jan 09 4:00 PM EST

HK$0.38

HK$0.00(0.00%)

Day’s Range― - ―

52-Week RangeHK$0.08 - HK$0.41

Previous CloseN/A

Volume100.00K

Average Volume (3M)611.69K

Market Cap

HK$26.56M

Enterprise ValueHK$38.89M

Total Cash (Recent Filing)HK$60.65M

Total Debt (Recent Filing)HK$12.00M

Price to Earnings (P/E)0.8

Beta0.45

Next Earnings

Nov 17, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.12

Shares Outstanding301,860,000

10 Day Avg. Volume861,937

30 Day Avg. Volume611,687

Financial Highlights & Ratios

PEG Ratio>-0.01

Price to Book (P/B)1.73

Price to Sales (P/S)2.33

P/FCF Ratio11.21

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Improved Balance SheetLower leverage indicates reduced balance-sheet strain and provides greater financial flexibility than in the prior year. The stronger equity position may help the company absorb project variability and support operations, although future benefits depend on converting revenue into durable operating profits.

Return To Positive Cash FlowThe return to positive operating and free cash flow is a constructive sign that the business generated cash after a negative 2025. If maintained, this could improve internal funding capacity, reduce reliance on external financing, and provide a firmer base for ongoing construction activity.

Revenue ReboundStronger revenue growth in 2026 suggests activity and demand recovered after the earlier contraction. Continued top-line expansion would improve the company’s ability to leverage its engineering and construction platform, though the benefit will depend on converting growth into healthier margins.

Bears Say

Thin Margins And Operating LossesVery thin gross margins leave little room to absorb cost increases, execution issues, or weaker project economics. Persistent operating losses also indicate that reported revenue has not yet translated into a durable operating model, making sustainable profitability a central risk over the coming quarters.

Low-Quality Earnings TurnaroundThe sharp swing to reported net profit appears disconnected from underlying operating performance, which remained loss-making. If the gain is non-recurring, it will not establish repeatable earnings power, leaving future results dependent on the company improving core project profitability rather than one-off items.

Volatile Cash GenerationAlthough cash flow turned positive in 2026, its history of large swings signals inconsistent conversion of activity into cash. Volatility can complicate budgeting and capital allocation, while relatively small cash generation versus revenue may leave less resilience if project timing or working-capital needs become unfavorable.

8217 FAQ

What was Luen Wong Group Holdings Ltd.’s price range in the past 12 months?

Luen Wong Group Holdings Ltd. lowest stock price was HK$0.07 and its highest was HK$0.41 in the past 12 months.

What is Luen Wong Group Holdings Ltd.’s market cap?

Luen Wong Group Holdings Ltd.’s market cap is HK$26.56M.

When is Luen Wong Group Holdings Ltd.’s upcoming earnings report date?

Luen Wong Group Holdings Ltd.’s upcoming earnings report date is Nov 17, 2026 which is in 16 days.

How were Luen Wong Group Holdings Ltd.’s earnings last quarter?

Luen Wong Group Holdings Ltd. released its earnings results on Jun 30, 2026. The company reported HK$0.006 earnings per share for the quarter.

Is Luen Wong Group Holdings Ltd. overvalued?

According to Wall Street analysts Luen Wong Group Holdings Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Luen Wong Group Holdings Ltd. pay dividends?

Luen Wong Group Holdings Ltd. does not currently pay dividends.

What is Luen Wong Group Holdings Ltd.’s EPS estimate?

Luen Wong Group Holdings Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Luen Wong Group Holdings Ltd. have?

Luen Wong Group Holdings Ltd. has 301,860,000 shares outstanding.

What happened to Luen Wong Group Holdings Ltd.’s price movement after its last earnings report?

Luen Wong Group Holdings Ltd. reported an EPS of HK$0.006 in its last earnings report. Following the earnings report the stock price went down -3.077%.

Which hedge fund is a major shareholder of Luen Wong Group Holdings Ltd.?

Currently, no hedge funds are holding shares in HK:8217

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Luen Wong Group Holdings Ltd.

"As an investment holding company, Ju Fu Tang Biotech Holdings Co., Ltd primarily delivers a comprehensive range of civil engineering, decoration, and renovation services across Hong Kong. Its extensive portfolio covers infrastructure development, specifically road and drainage systems. This encompasses the building and enhancement of local roads and carriageway junctions, along with related facilities such as footpaths, planting zones, drainage networks, sewer lines, water mains, and utility relocation solutions. Additionally, the company undertakes foundational structural projects, including the erection of reinforced concrete structures for bridges and retaining walls. Furthermore, their expertise extends to site preparation, involving excavation and filling operations essential for new site development or future construction. The entity previously operated under the name WMHW Holdings Limited before rebranding as Ju Fu Tang Biotech Holdings Co., Ltd in September 2025. Established in 2015, the firm maintains its headquarters in Causeway Bay, Hong Kong."